Ads
related to: does mobilify really work for sleep apnea medication treatment
Search results
Results from the WOW.Com Content Network
The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...
The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.
The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...
"This metric helps your doctor determine the severity of your sleep apnea and can help guide treatment choices." Obstructive sleep apnea can be categorized as mild, moderate or severe. Mild sleep ...
Without treatment, the sleep deprivation and lack of oxygen caused by sleep apnea increases health risks such as cardiovascular disease, aortic disease (e.g. aortic aneurysm), [163] high blood pressure, [164] [165] stroke, [166] diabetes, clinical depression, [167] weight gain, obesity, [64] and even death.
Solriamfetol is used to promote wakefulness in the treatment of excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea in adults. [1] It appears to be more effective in improving excessive daytime sleepiness associated with obstructive sleep apnea than certain other wakefulness-promoting agents including modafinil, armodafinil, and pitolisant.
Ads
related to: does mobilify really work for sleep apnea medication treatment